Suppr超能文献

人肝硬化中S-腺苷-L-甲硫氨酸合成酶高分子量形式的特异性缺失

Specific loss of the high-molecular-weight form of S-adenosyl-L-methionine synthetase in human liver cirrhosis.

作者信息

Cabrero C, Duce A M, Ortiz P, Alemany S, Mato J M

机构信息

Fundacion Jimenez Diaz, Madrid, Spain.

出版信息

Hepatology. 1988 Nov-Dec;8(6):1530-4. doi: 10.1002/hep.1840080610.

Abstract

We have measured the activity of S-adenosyl-L-methionine synthetase, the ratio between the high- and low-molecular-weight forms of this enzyme and the concentration of S-adenosyl-L-methionine in liver biopsies from a group of controls (n = 6) and in six cirrhotics (five posthepatitic and one alcoholic). The total activity of S-adenosyl-L-methionine synthetase was markedly reduced in cirrhosis (37.5% of that found in the control group). This was due to a specific reduction in the high-molecular-weight S-adenosyl-L-methionine synthetase in the group of cirrhotics (73.9 pmoles per min per mg protein) when compared with that observed in controls (460.3 pmoles per min per mg protein). Despite this reduction in the rate of synthesis of S-adenosyl-L-methionine (the high-molecular-weight form of the enzyme is 15 times more active than the low-molecular-weight form at physiological concentration of substrates), the concentration of this metabolite was the same in the control group (17.3 +/- 2.6 microM) and in the group of cirrhotics (17.8 +/- 3.1 microM). To explain these findings, it is postulated that in human liver, where the concentration of S-adenosyl-L-methionine is lower than the Km values of a variety of enzymes that use this metabolite (around 50 to 100 microM), a reduction in the synthesis of S-adenosyl-L-methionine is compensated by a reduction in the rate of utilization of this molecule without affecting the intrahepatic concentration of S-adenosyl-L-methionine.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

我们测定了一组对照组(n = 6)和六名肝硬化患者(五名肝炎后肝硬化患者和一名酒精性肝硬化患者)肝脏活检组织中S-腺苷-L-甲硫氨酸合成酶的活性、该酶高分子量和低分子量形式之间的比例以及S-腺苷-L-甲硫氨酸的浓度。肝硬化患者中S-腺苷-L-甲硫氨酸合成酶的总活性显著降低(为对照组的37.5%)。这是由于肝硬化组中高分子量S-腺苷-L-甲硫氨酸合成酶的特异性降低(每分钟每毫克蛋白质73.9皮摩尔),与对照组(每分钟每毫克蛋白质460.3皮摩尔)相比。尽管S-腺苷-L-甲硫氨酸的合成速率降低(在生理底物浓度下,该酶的高分子量形式比低分子量形式活性高15倍),但该代谢物在对照组(17.3±2.6微摩尔)和肝硬化组(17.8±3.1微摩尔)中的浓度相同。为了解释这些发现,推测在人类肝脏中,S-腺苷-L-甲硫氨酸的浓度低于多种使用该代谢物的酶的Km值(约50至100微摩尔),S-腺苷-L-甲硫氨酸合成的减少通过该分子利用速率的降低得到补偿,而不影响肝脏内S-腺苷-L-甲硫氨酸的浓度。(摘要截短于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验